Ann: Trading Halt, page-163

First 163 Last

Share
Profile

Follow
Luke7394

53 Posts.

12

25/06/21

10:19

Post #: 54063395
Share

Originally posted by Karl89: ↑

So you are saying if this was done at 50 or 60c you would have been happy? You are complaining about an extra $10-20m pre fees! you have to start thinking timelines here.

When 200k oz are running through the plant, you think you will be thinking about that little amount of cash? they want cash now, drills moving now….

I want those drills working around the clock… I want more gold found. Moderate grade? I’m happy, fire up that sag mill, let’s blow 4.5mt out of the water...what I’m after, what I think we all want, is a line randgold repeated constantly…. Potential of find another “Morila size deposit”… let’s find it, it’s there… Samacline is just the tip of the tail of Willy the Whale hiding just east of the Gorilla.

seems odd you would want to sell out of a company that will now have the cash for drilling and a bank of historical data to lean on… previous high grade results… serious exploitation sites already started… oh and a gigantic plant sitting there ready… but your money… I just don’t understand why if the raise was at 60c, you’d be fine but at 40c the sky is falling, management is terrible, the gold In the ground is a lie and mike was the wrong person as MD … this is no longer a junior explorer that has $5m in the bank and a market cap of $20m.

The way I see it, they are pushing a very productive timeline with further acquisitions on the not to distant horizon… Morila needs money smashed at it now, as much excitement created asap before interest moves on to the next site and Morila returns to that unloved one of years past under randgold/ barracks/ Anglo.

Expand

Well said mate, Couldn't agree more.

FFX Price at posting: 45.0¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

There are more pages in this discussion • 53 more messages in this thread...

First 163 Last

Add FFX (ASX) to my watchlist

Ann: Trading Halt, page-163

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Featured News